Lhassane Ismaïli

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease

David Pertuit, Brice Moulari, Thomas Betz et al. · Journal of Controlled Release · 2007 · 122 citations

Pharmacy, Pharmaceutics, Pharmacology +14

The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators

Mohamed Benchekroun, Alejandro Romero, Javier Egea et al. · Journal of Medicinal Chemistry · 2016 · 102 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H₃R Antagonism for Neurodegenerative Diseases

Óscar M. Bautista‐Aguilera, Stefanie Hagenow, Alejandra Palomino‐Antolín et al. · Angewandte Chemie International Edition · 2017 · 101 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and antioxidant activity evaluation of new hexahydropyrimido[5,4-c]quinoline-2,5-diones and 2-thioxohexahydropyrimido[5,4-c]quinoline-5-ones obtained by Biginelli reaction in two steps

Lhassane Ismaïli, Arulraj Nadaradjane, Laurent Nicod et al. · European Journal of Medicinal Chemistry · 2007 · 87 citations

Pharmacy, Chemistry, Medicinal Chemistry +8

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy

José Marco‐Contelles, Mercedes Unzeta, Irene Bolea et al. · Frontiers in Neuroscience · 2016 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17